Market News Archives

The Beautiful Game Meets Basis Points: Inside the $10 Billion World Cup Prediction Market & The USMNT Surge -( $COIN $DKNG $HOOD )

by John F. Heerdink, Jr. July 5, 2026 573Views 0Likes

The 2026 FIFA World Cup is turning into Wall Street’s favorite summer blockbuster, supercharging prediction markets, boosting platform revenues, and giving investors a new data-rich playground that feels more like trading macro than betting on soccer. World Cup Becomes A New Asset…

From Couch to $50 Copay: Medicare’s Bridge Program and the Long‑Only Case for Obesity as a Chronic‑Care Asset Class -( $LLY MODD $NVO )

by John F. Heerdink, Jr. July 5, 2026 453Views 0Likes

Medicare’s new $50 GLP‑1 program and a fresh wave of insulin‑delivery innovation are quietly rewriting the economics of chronic care—and investors who blink risk missing a secular health‑tech rerating hiding inside the fine print. At the same time, companies like Modular Medical…

The Great Oil Mood Swing: Why Today’s Glut Could Be Tomorrow’s Opportunity

by John F. Heerdink, Jr. July 5, 2026 371Views 0Likes

Oil’s latest whipsaw—from war-premium spike to supply‑glut slide—has turned the crude market into a live‑fire drill for portfolio managers, but beneath the drama sits a quietly constructive setup for patient energy investors. The Day Oil Remembered Gravity For a brief, heady moment,…

Hot Dogs, High Returns and Home‑Field Advantage: America250 Meets the S&P 500 and USMNT -( $SPX $SPY )

by John F. Heerdink, Jr. July 4, 2026 399Views 0Likes

America at 250 offers investors a rare chance to zoom out: a quarter-millennium of political experiment, market compounding and—this summer—a home‑soil World Cup where the USMNT is finally expected to play offense in both soccer and sentiment. A Semiquincentennial Worth Trading On…

The Immune System Strikes Back: Why Biogen’s M&A Spree and Eupraxia’s Trial Progress Deserve a Place On Your Radar -( $APLS $BIIB $EPRX )

by John F. Heerdink, Jr. July 3, 2026 562Views 0Likes

Biogen Inc. (Nasdaq: BIIB) is quietly rewriting its own playbook, stitching together a next‑generation immunology franchise with a $1 billion bet on private upstart RayThera Inc. and a freshly closed $5.6 billion takeover of Apellis Pharmaceuticals Inc. (Nasdaq: APLS) that gives the…

July 2, 2026 – Wall Street Braces for Long July 4th Weekend: Cooler Jobs, Hot Gas, and AI Rotation -( $AMWL $EPRX $MODD $RKLB $SMWB Rise This Week! )

by John F. Heerdink, Jr. July 2, 2026 1746Views 0Likes

U.S. equities traded in a cautious, rotation-driven pattern on Thursday, July 2, 2026, as investors digested a cooler June jobs report, four‑year‑high gasoline prices, and a holiday-shortened trading week ahead of the Independence Day market closure. Headline market moves The major averages…

Soft Landing, Hard Numbers: Why a 57,000‑Job Economy May Love $RIVN, $SMWB, and $MODD

by John F. Heerdink, Jr. July 2, 2026 261Views 0Likes

The market walked into June’s jobs report braced for a slowdown and still managed to be surprised by how leisurely the hiring pace has become—with a few high‑conviction growth stories quietly stealing the show in EVs, digital data, and med‑tech. A “Goldilocks‑ish”…

July 1, 2026 – Dow Nears Record, Nasdaq Sulks: Warsh Talks Inflation While META Monetizes Machine Mojo -( $AMWL $EPRX $LIME $META $MODD $SMWB $SPCX Rise! )

by John F. Heerdink, Jr. July 1, 2026 1693Views 0Likes

US stocks opened the second half on a mixed footing Wednesday, with the Dow Jones Industrial Average inching near record territory before retreating slightly, while the Nasdaq Composite slipped as investors rotated out of mega-cap tech and digested fresh commentary from Federal…

When Simplicity Becomes a Moat: How Modular Medical’s Pivot Pump Could Reprice Diabetes Convenience -( $ABT $MODD $LLY )

by John F. Heerdink, Jr. July 1, 2026 576Views 0Likes

Modular Medical’s (NASDAQ: MODD) latest FDA submission turns a quiet diabetes niche into a live‑wire medtech story, with an underappreciated, tubeless insulin “Pivot” that is starting to look less like a gadget and more like a platform. A Small Cap With Big…

The ‘Almost‑Pumper’ Revolution: Modular Medical’s Pivot And The Art Of Making Diabetes Easier -( $MODD )

by John F. Heerdink, Jr. June 30, 2026 497Views 0Likes

Modular Medical’s Pivot™ tubeless insulin patch pump is quietly staging the kind of commercial debut that makes both endocrinologists and investors sit up a little straighter. With first patients now trained and actively dosing in the wild as of this week, the…

Market News

Your Guide To Staying Informed In The Markets